Rethinking DCIS: What the COMET Trial Means for Patients

Can women with low-risk ductal carcinoma in situ (DCIS) safely avoid aggressive treatment and be monitored with active surveillance?

Your gift is doubled through December 31.

Donate Now
Date
November 3, 2025